Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-01ALLO144Beneski Benjamin Machinas plan to sell securities of Allogene Therapeutics, Inc. under Form 144MEDIUM
Beneski Benjamin Machinas filed Form 144 to notify SEC of plan to sell 2867 units of Allogene Therapeutics, Inc. securities around 2026-04-01, with aggregate market value of $7,167.50. The total outstanding units is 243777920.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Small CapBiotechnology
2026-04-01ARQT144Howard Welgus plan to sell securities of Arcutis Biotherapeutics, Inc. under Form 144MEDIUM
Howard Welgus filed Form 144 to notify SEC of plan to sell 10000 units of Arcutis Biotherapeutics, Inc. securities around 2026-04-01, with aggregate market value of $238,800.86. The total outstanding units is 122492192.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in ...
Mid CapBiotechnology
2026-04-01AVTX144CHRISTOPHER SULLIVAN plan to sell securities of AVALO THERAPEUTICS INC under Form 144MEDIUM
CHRISTOPHER SULLIVAN filed Form 144 to notify SEC of plan to sell 15959 units of AVALO THERAPEUTICS INC securities around 2026-04-01, with aggregate market value of $238,267.87. The total outstanding units is 22788452.0. The amount planned to be sold represents 0.07% of total outstanding units; ...
Small CapBiotechnology
2026-04-01Allogene Therapeutics, Inc.144Beneski Benjamin Machinas plan to sell securities of Allogene Therapeutics, Inc. under Form 144DuplicateMEDIUM
Beneski Benjamin Machinas filed Form 144 to notify SEC of plan to sell 2867 units of Allogene Therapeutics, Inc. securities around 2026-04-01, with aggregate market value of $7,167.50. The total outstanding units is 243777920.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Small CapBiotechnology